Pfizer Aktie
WKN: 852009 / ISIN: US7170811035
23.07.2018 13:43:54
|
Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518
(RTTNews) - Leap Therapeutics, Inc. (LPTX) announced a collaboration agreement with Merck KGaA, and Pfizer to evaluate Leap's GITR agonist, TRX518, in combination with avelumab, a human anti-PD-L1 IgG1 monoclonal antibody, and chemotherapy.
Leap will be conducting a Phase I/II clinical trial in advanced solid tumors including expansion populations in patients with relapsed/refractory ovarian, breast, and prostate cancers. The study is expected to begin enrolling patients in the first quarter of 2019.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
Analysen zu Pfizer Inc.mehr Analysen
04.04.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
07.03.25 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.02.25 | Pfizer Kaufen | DZ BANK | |
05.02.25 | Pfizer Buy | Goldman Sachs Group Inc. | |
05.02.25 | Pfizer Neutral | UBS AG |
Aktien in diesem Artikel
Pfizer Inc. | 20,96 | -4,84% |
|